| |
Stem cell research is very dynamic with research trends, focus, and approaches evolving extremely rapidly. The tool market has to quickly adapt to these challenges and develop innovative tools that address and accelerate research accomplishments.
New analysis from Frost & Sullivan (drugdiscovery.frost.com), Strategic Analysis of the European Stem Cell Research Tools Market, finds that the market earned revenues of $131.7 million in 2010 and estimates this to reach $322.0 million in 2017. The segments covered include: bio-imaging and microscopy, cell biology tools, immunochemical, molecular biology tools, and protein biochemistry tools.
"Firms with the capacity to supply tools for stem cell research will increase as the science matures," notes Frost & Sullivan Senior Research Analyst Divyaa Ravishankar. "Soon demand and supply will achieve a degree of equilibrium."
Already, a sizeable stem cell research products market has emerged. Another positive sign for the market has been enhanced industry- academic collaboration.
A key step forward has been the stem cell regulations in a few countries allowing the use of certain cell lines. In some countries such as France, for instance, stem cell regulations are being renewed for the procurement and use of stem cells.
"Such trends indicate the potential for a regulatory climate that would be far less restrictive than the current scenario," adds Divyaa Ravishankar. "This, together with the prospect of diverse applications within the healthcare arena, is bolstering the future of the market."
However, the lack of venture capitalists (VC) poses a grave challenge. VC funding is driven by investment concerns, with companies bidding to double their money every few years in order to return revenue to the fund's investors. As a high risk venture, stem cell technology does not exactly present an attractive investment proposition.
"While these are financial concerns, from the technological standpoint, the challenge remains to understand the basic biology behind stem cells," remarks Divyaa Ravishankar. "There is an urgent need to design and develop specific technology platforms that enhance the production, genetic stability and integration of transplanted cells."
If you are interested in more information on this study, please send an e-mail with your contact details to Janique Morvan, Corporate Communications, at janique.morvan[.]frost.com.
Strategic Analysis of the European Stem Cell Research Tools Market is part of the Clinical Diagnostics Growth Partnership Services programme, which also includes research in the following markets: European PCR Reagent Market for Research and Clinical Diagnostics and European Next Generation Sequencing Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit frost.com.
Strategic Analysis of the European Stem Cell Research Tools Market / M72F-55
|
janique.morvan[.]frost.com 
